+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Allergic Contact Dermatitis Drugs"

Contact Dermatitis - Pipeline Insight, 2024 - Product Thumbnail Image

Contact Dermatitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Global Eczema Therapeutics Market 2024-2028 - Product Thumbnail Image

Global Eczema Therapeutics Market 2024-2028

  • Report
  • April 2024
  • 172 Pages
  • Global
From
From
From
Contact Dermatitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Contact Dermatitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Contact Dermatitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Contact Dermatitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 47 Pages
  • Global
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Allergic Contact Dermatitis Drugs are a type of Dermatological Drugs used to treat skin conditions caused by an allergic reaction to a substance. These drugs are typically used to reduce inflammation, itching, and other symptoms associated with the condition. Commonly used Allergic Contact Dermatitis Drugs include topical corticosteroids, topical calcineurin inhibitors, and oral antihistamines. These drugs are often used in combination with other treatments such as phototherapy and topical immunomodulators. The Allergic Contact Dermatitis Drugs market is highly competitive, with a range of companies offering products to treat the condition. Some of the major players in the market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Mylan. Other companies in the market include Sun Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories. Show Less Read more